Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Heather Sprenger
Observed names:
H.L. Sprenger,
Heather L. Sprenger
Institution:
Frontier Science & Technology Research Foundation, Inc.
Observed institution:
Frontier Science & Technology Research Foundation, Inc.
ORCID:
0009-0008-0678-8333
Observed ORCID:
0009-0008-0678-8333
OpenAlex ID:
A5030784860
Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV: Mechanistic Substudy of the REPRIEVE Randomized Clinical Trial
2024
·
Michael T. Lu
, Heather Ribaudo
, et al.
·
JAMA Cardiology
·
109
Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220
2010
·
E.T. Overton
, M. Kang
, et al.
·
Vaccine
·
35
The importance of methods for site performance evaluation in REPRIEVE, a longitudinal, global, multicenter trial
2022
·
Evelynne S. Fulda
, Carl J. Fichtenbaum
, et al.
·
Contemporary Clinical Trials
·
4
Short Course Therapy With Glecaprevir/Pibrentasvir for Early Hepatitis C Virus Infection: PURGE-C
2025
·
Arthur Y Kim
, Minhee Kang
, et al.
·
Clinical Infectious Diseases
·
2
Clinical Pharmacology Quality Assurance Program for Global HIV and Co‐Infection Drug Development
2026
·
Robin DiFrancesco
, Troy D. Wood
, et al.
·
Clinical Pharmacology & Therapeutics
·
1
琵琶湖に生息するDaphnia(ミジンコ)の分類学的検討
2002
·
石田 聖二
, 占部 城太郎
, et al.
Show more works
View as search
Works count:
6
Citation count:
151
H-index:
3
I10-index:
2
Year
Topic
Type